Tackling the threat of antimicrobial resistance in neonates and children: outcomes from the first WHO-convened Paediatric Drug Optimisation exercise for antibiotics
Alasdair Bamford(Great Ormond Street Hospital for Children NHS Foundation Trust), Martina Penazzato(World Health Organization), Tiziana Masini(World Health Organization), Benedikt Huttner(University Hospital of Geneva), Devika Dixit(University of Calgary), Mike Sharland(St George's, University of London), Phoebe Williams(The University of Sydney), Jennifer Cohn(University of Pennsylvania), Bernadette Cappello(World Health Organization), Hatim Sati(World Health Organization), Yasir Bin Nisar, Wilson Were, Valeria Gigante(World Health Organization)
Cited by 21
Related Papers
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
The <i>WHO AWaRe (Access, Watch, Reserve) antibiotic book</i> and prevention of antimicrobial resistance
|Bulletin of the World Health Organization|2023|276
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings
|International Journal of Infectious Diseases|2021|256
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed
|Archive ouverte UNIGE (University of Geneva)|2022|221
Impact of climate change and natural disasters on fungal infections
|The Lancet Microbe|2024|204